X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Novartis to acquire The Medicines Company for USD 9.7 bn

    Beovu, Made By Novartis, Earns A Recommendation From NICE

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Moderna To introduce The Fusion Of COVID-19 And Flu Booster

    September May See Advent of Revised COVID-19 Booster Shots

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    FDA Experts Recommend Changing COVID Jab Formulation In Fall

    FDA Continues To Deal With Issues With Expedited Clearance

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Paxlovid Allowed By FDA To Sell At Certified Pharmacies

    Pfizer Has Long-Term Plans For Paxlovid, Comirnaty, COVID-19

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Novartis to acquire The Medicines Company for USD 9.7 bn

    Beovu, Made By Novartis, Earns A Recommendation From NICE

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

    Moderna To introduce The Fusion Of COVID-19 And Flu Booster

    September May See Advent of Revised COVID-19 Booster Shots

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    First Patient Adopting TAC-001 Has Been Announced By Tallac

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream

    FDA Experts Recommend Changing COVID Jab Formulation In Fall

    FDA Continues To Deal With Issues With Expedited Clearance

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Test For Sterility of Cell Culture Using Ratio of NA To NAM

    Paxlovid Allowed By FDA To Sell At Certified Pharmacies

    Pfizer Has Long-Term Plans For Paxlovid, Comirnaty, COVID-19

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

With $6.26bn In Q1, The Indian Pharma Exports Grew By 8%

Content Team by Content Team
3rd August 2022
in Middle East and South Asia, News, Packaging & Logistic
EMA Advises Recall of AbbVie, Biogen MS Drug

Indian pharmaceutical exports increased by 8% in the first quarter of the current fiscal year to $6.26 billion, with officials anticipating a 10% increase by year’s end.

Pharma exports to the European Union and other CIS countries, which were affected by the ongoing war in Ukraine and subsequent limitations, are expected to improve once the situation returns to normal, according to the Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil), Udaya Bhaskar. The council happens to be under the Central Government’s department of commerce.

Bhaskar added that there was an 8% increase in exports during the first quarter. In the first quarter, they anticipate a gain of 3.6% in exports to the US, the destination of 30% of India’s exports. Once the situation around the Russia-Ukraine war calms, Bhaskar said he was optimistic that exports to the EU and CIS (Commonwealth of Independent States) would improve. In FY 22-23, exports might reach about $27 billion.

India’s pharmaceutical exports totaled $24.61 billion in FY22, an increase of 1% over FY21. According to recent comments from Union Minister Mansukh Mandaviya, exports of Made in India medicinal products increased by 146% from April to June 2022 compared to the same period in 2013.

The official added that COVID-19 vaccine shipments, which currently total 239 million doses to more than 100 nations, are on the rise. Regarding the current situation between Russia and Ukraine, he said that the former is important to India and stands sixth in terms of pharmaceutical exports.

According to him, about 60% of all exports to CIS nations go to Russia, and as a result of the war, those numbers are declining. He also mentioned how difficult it had been to export to Europe. He predicted that India may see an increase in exports of another $1 billion if the situation improved.

In order to address the concerns associated with the lack of pharmaceutical items there, he claimed that Pharmexcil and the Russian Embassy in New Delhi had arranged a webinar with the representatives of the Russian Trade Commission, bankers, as well as Indian and Russian businessmen.

The webinar’s focus, according to him, is on how to increase Indian exports and how Indian and Russian businesses should handle the problems.

The webinar was attended by Deputy Trade Commissioner of the Russian Federation-India, Evgeny Griva, Uday Bhaskar, high-level government representatives, notable Russian pharmaceutical institutes, and over 110 Indian enterprises.

Previous Post

Big Data Steering Group To Better Data Effectiveness, Search

Related Posts

Big Data Steering Group To Better Data Effectiveness, Search
IPR Data Management

Big Data Steering Group To Better Data Effectiveness, Search

3rd August 2022
Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK
Facilities & Operation

Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK

3rd August 2022
Korean Company GenKOre Offering Genetic Base-Editing Tech
News

Korean Company GenKOre Offering Genetic Base-Editing Tech

3rd August 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
FDA Approvals

Beovu, Made By Novartis, Earns A Recommendation From NICE

2nd August 2022
Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill
FDA Approvals

Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill

2nd August 2022
Moderna To introduce The Fusion Of COVID-19 And Flu Booster
Drug Development

September May See Advent of Revised COVID-19 Booster Shots

1st August 2022

Latest News

EMA Advises Recall of AbbVie, Biogen MS Drug
Middle East and South Asia

With $6.26bn In Q1, The Indian Pharma Exports Grew By 8%

3rd August 2022
Big Data Steering Group To Better Data Effectiveness, Search
IPR Data Management

Big Data Steering Group To Better Data Effectiveness, Search

3rd August 2022
Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK
Facilities & Operation

Europe To Obtain 85 Million Pandemic Flu Vaccines From GSK

3rd August 2022
Korean Company GenKOre Offering Genetic Base-Editing Tech
News

Korean Company GenKOre Offering Genetic Base-Editing Tech

3rd August 2022
Novartis to acquire The Medicines Company for USD 9.7 bn
FDA Approvals

Beovu, Made By Novartis, Earns A Recommendation From NICE

2nd August 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In